1. Medtech Insight
  2. >>Policy & Regulation
  3. >>Approvals

Eko’s AI Algorithm To Detect Heart Conditions Cleared By US FDA

US regulators have cleared a suite of cloud-based artificial intelligence software intended to be used with Eko’s digital stethoscopes to detect certain heart problems. The company says the AI algorithms are the first of its kind to be cleared by the US FDA.

Human heart. Digital technologies in medicine. Innovations in healthcare. 3D illustration on a colorful background

The US Food and Drug Administration cleared a suite of Eko’s cloud-based software apps that use artificial intelligence with a digital stethoscopes to assist physicians in detecting potential cardiac conditions such as heart murmurs and atrial fibrillation, the company announced on 28 January.

According to Eko, the algorithms cleared by the FDA are the first of their kind designed to be used on Eko's digital stethoscopes that were released in 2015 and now...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Approvals

More from Policy & Regulation